Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.
Journal: JAMA
Published: August 13, 2026
A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator that promotes prostate cancer proliferation.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET Era.
Journal: Cancers
Published: December 21, 2025
Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning: An ASTRO Consensus Paper.
Journal: Practical radiation oncology
Published: September 23, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy.
Journal: European urology oncology
Published: April 16, 2025
Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005.
Journal: Journal of magnetic resonance imaging : JMRI
Published: April 01, 2025
The Evolving Management of Radiorecurrent Prostate Cancer.
Journal: Seminars in radiation oncology
Published: March 14, 2025
Leveraging Radiotherapy Data for Precision Oncology: Veterans Affairs Granular Radiotherapy Information Database.
Journal: JCO clinical cancer informatics
Published: February 12, 2025
A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: December 10, 2024
ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update.
Journal: Journal of the American College of Radiology : JACR
Published: August 22, 2024
The Importance of Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: July 24, 2024
Last Updated: 09/26/2026